Trulove, Susan2015-10-292015-10-292009-04-13http://hdl.handle.net/10919/61876Researchers from Virginia Tech and Molsoft LLC have received a five-year, $3.557 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to continue their promising work on a new class of resistance-breaking insecticides to reduce malaria transmission.text/htmlIn CopyrightCollege of SciencePress releaseVirginia Tech. University Relations